1. Home
  2. EVO vs KMT Comparison

EVO vs KMT Comparison

Compare EVO & KMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • KMT
  • Stock Information
  • Founded
  • EVO 1993
  • KMT 1938
  • Country
  • EVO Germany
  • KMT United States
  • Employees
  • EVO N/A
  • KMT N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • KMT Industrial Machinery/Components
  • Sector
  • EVO Health Care
  • KMT Industrials
  • Exchange
  • EVO Nasdaq
  • KMT Nasdaq
  • Market Cap
  • EVO 1.5B
  • KMT 1.6B
  • IPO Year
  • EVO 2021
  • KMT N/A
  • Fundamental
  • Price
  • EVO $4.30
  • KMT $20.80
  • Analyst Decision
  • EVO Buy
  • KMT Hold
  • Analyst Count
  • EVO 2
  • KMT 5
  • Target Price
  • EVO $5.90
  • KMT $25.20
  • AVG Volume (30 Days)
  • EVO 154.6K
  • KMT 945.0K
  • Earning Date
  • EVO 05-06-2025
  • KMT 05-07-2025
  • Dividend Yield
  • EVO N/A
  • KMT 3.85%
  • EPS Growth
  • EVO N/A
  • KMT 2.33
  • EPS
  • EVO N/A
  • KMT 1.38
  • Revenue
  • EVO $851,944,444.00
  • KMT $1,993,706,000.00
  • Revenue This Year
  • EVO $11.29
  • KMT N/A
  • Revenue Next Year
  • EVO $13.20
  • KMT $1.66
  • P/E Ratio
  • EVO N/A
  • KMT $15.04
  • Revenue Growth
  • EVO 1.50
  • KMT N/A
  • 52 Week Low
  • EVO $2.84
  • KMT $17.30
  • 52 Week High
  • EVO $5.68
  • KMT $32.18
  • Technical
  • Relative Strength Index (RSI)
  • EVO 61.35
  • KMT 60.25
  • Support Level
  • EVO $3.91
  • KMT $19.42
  • Resistance Level
  • EVO $4.38
  • KMT $21.25
  • Average True Range (ATR)
  • EVO 0.13
  • KMT 0.62
  • MACD
  • EVO 0.01
  • KMT 0.26
  • Stochastic Oscillator
  • EVO 86.89
  • KMT 82.49

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

Share on Social Networks: